Ehsan Ghorani

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Actinomycin D versus etoposide, methotrexate, actinomycin D/cyclophosphamide, and vincristine as second-line treatment in low-risk gestational trophoblastic neoplasia with primary methotrexate resistance.

Actinomycin D versus etoposide, methotrexate, actinomycin D/cyclophosphamide, and vincristine as second-line treatment in low-risk gestational trophoblastic neoplasia with primary methotrexate resistance.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 18, 2026

Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.

Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 06, 2026

Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours.

Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours.

Journal: British journal of cancer
Published: November 04, 2025

Current and future treatments for low-risk gestational trophoblastic neoplasia.

Current and future treatments for low-risk gestational trophoblastic neoplasia.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 16, 2025

Erratum to 'Controversies in malignant ovarian germ cell tumors' [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101670].

Erratum to 'Controversies in malignant ovarian germ cell tumors' [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101670].

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 05, 2025

How to design a ROCI (Response Over Continuous Intervention) randomised trial: guidance and a case study.

How to design a ROCI (Response Over Continuous Intervention) randomised trial: guidance and a case study.

Journal: BMC medical research methodology
Published: March 25, 2025

Controversies in malignant ovarian germ cell tumors.

Controversies in malignant ovarian germ cell tumors.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 20, 2025

Future Directions for Gestational Trophoblastic Disease.

Future Directions for Gestational Trophoblastic Disease.

Journal: Hematology/oncology clinics of North America
Published: September 25, 2024

Cancer cell-intrinsic mechanisms driving acquired immune tolerance.

Cancer cell-intrinsic mechanisms driving acquired immune tolerance.

Journal: Immunity
Published: May 11, 2023

Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.

Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 02, 2023

Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm.

Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm.

Journal: Gynecologic and obstetric investigation
Published: April 25, 2023

Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy.

Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 06, 2023
Showing 1-12 of 46

Last Updated: 09/26/2026